MarketCapTrends
VYGR
Voyager Therapeutics Inc. (VYGR)
NASDAQ · Healthcare

Voyager Therapeutics Inc. Shareholder Equity 2015–2025

Voyager Therapeutics Inc. annual/quarterly shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Voyager Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 196.1M, a 34.59% decrease year-over-year.
  • Voyager Therapeutics Inc. shareholder equity for 2025 were 196.1M, a 34.59% decrease from 2024.
  • Voyager Therapeutics Inc. shareholder equity for 2024 were 299.8M, a 26.84% increase from 2023.
  • Voyager Therapeutics Inc. shareholder equity for 2023 were 236.3M, a 300.41% increase from 2022.
  • Voyager Therapeutics Inc. shareholder equity for 2022 were 59.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Voyager Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$196
2024$300
2023$236
2022$59
2021$95
2020$154
2019$100
2018$46
2017$134
2016$136
2015$169
Voyager Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$196
2024-12-31$300
2023-12-31$236
2022-12-31$59
2021-12-31$95
2020-12-31$154
2019-12-31$100
2018-12-31$46
2017-12-31$134
2016-12-31$136
2015-12-31$169

Voyager Therapeutics Inc. Shareholder Equity — FAQ

Voyager Therapeutics Inc. (VYGR) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VYGR's shareholder equity history?

The chart and table above show Voyager Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.